https://tws119inhibitor.com/qu....antifying-the-partic
A particular new radiotracer to detect SGLT activity was introduced, Me4FDG, and this provides a chance to explore the possibility part of SGLTs in supporting tumefaction glycolysis. In this brief analysis, We highlight the introduction of Me4FDG and our initial studies of Me4FDG PET in cancer tumors patients. We find that the renal isoform, SGLT2, is expressed in pancreatic and prostate tumors and glioblastomas, and Me4FDG PET introduces a unique way to image tumors. As SGLT2
Like
Comment
Share
